2021-05-12 Senate Journal

Relating to designating Gabapentin as a monitored drug having a substantial potential for abuse.

hist134019 No action taken on May 7, 2021.

hist134020 Referred to the joint committee for review of Administrative Rules, May 12, 2021.

PATRICK TESTIN

Chairperson

_____________

Messages from the Assembly

By Edward A. Blazel, chief clerk.

Mr. President:

I am directed to inform you that the Assembly has

Adopted and asks concurrence in:

hist133983 Assembly Joint Resolution 9

hist133984 Assembly Joint Resolution 47

Passed and asks concurrence in:

hist133985 Assembly Bill 45

hist133986 Assembly Bill 46

hist133987 Assembly Bill 59

hist133988 Assembly Bill 173

hist133989 Assembly Bill 226

Concurred in:

hist133967 Senate Bill 17

hist133968 Senate Bill 24

hist133969 Senate Bill 46

hist133970 Senate Bill 51

hist133971 Senate Bill 52

hist133972 Senate Bill 102

hist133973 Senate Bill 105

hist133974 Senate Bill 107

hist133975 Senate Bill 112

hist133976 Senate Bill 168

hist133977 Senate Bill 170

hist133978 Senate Bill 171

hist133979 Senate Bill 208

hist133980 Senate Bill 266

hist133981 Senate Joint Resolution 21

hist133982 Senate Joint Resolution 25

313